Sequenom Considering Illumina, SOLiD for Down Syndrome Test; Plans to Launch LDT by End of 2011

Following clinical validation studies, Sequenom wants to launch a laboratory-developed test that runs on a next-generation sequencing platform by the end of 2011, and file for premarket approval by the end of the following year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.